monosodium (([5-(1,1-dimethylethyl)thiazol-2-yl]methyl)([(4-(4-[4-(1-propylbutyl)phenoxy]methyl)phenyl)thiazol-2-yl]methyl)amino)acetate, a specific protein tyrosine phosphatase 1B inhibitor in vitro and in vivo, mixed-type inhibition mode versus PTPB1, overview kanjone - karanjin - L-Tartrate - weak licochalcone A - licochalcone E - lithocholic acid - natural inhibitor against PTP1B lobaric acid - a depsidone-type compound, isolated from a methanol extract of the Antarctic lichen Stereocaulon alpinum lupenone - isolated from Sorbus commixta stem bark, inhibits PTP1B in a selective and noncompetitive manner lupeol - isolated from Sorbus commixta stem bark, inhibits PTP1B in a selective and noncompetitive manner maslinic acid menadione inhibits Cdc25B irreversibly methyl (4R)-4-[(1R,3aS,3bS,10aR,10bS,12aR)-8-amino-6,6,10a,12a-tetramethyl-2,3,3a,3b,4,6,10,10a,10b,11,12,12a-dodecahydro-1H-cyclopenta[7,8]phenanthro[2,3-d][1,3]thiazol-1-yl]pentanoate - - methyl (4R)-4-[(1R,3aS,3bS,11aR,11bS,13aR)-6,6,11a,13a-tetramethyl-2,3,3a,3b,4,6,11,11a,11b,12,13,13a-dodecahydro-1H-cyclopenta[5,6]naphtho[1,2-g]quinoxalin-1-yl]pentanoate - - methyl (4R)-4-[(E)-2-(4-bromophenyl)ethenyl]-6-(propan-2-yl)-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate - methyl (4R)-4-[(E)-2-(4-bromophenyl)ethenyl]-6-tert-butyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate - methyl (4R)-4-[(E)-2-(4-chlorophenyl)ethenyl]-6-(propan-2-yl)-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate methyl (4R)-4-[(E)-2-(4-fluorophenyl)ethenyl]-6-(propan-2-yl)-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate methyl (4R)-4-[(E)-2-(4-methoxyphenyl)ethenyl]-6-(propan-2-yl)-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate - methyl (4R)-4-[(E)-2-phenylethenyl]-6-(propan-2-yl)-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate - methyl (4R)-6-(propan-2-yl)-2-sulfanylidene-4-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,2,3,4-tetrahydropyrimidine-5-carboxylate - methyl (4R)-6-tert-butyl-2-sulfanylidene-4-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,2,3,4-tetrahydropyrimidine-5-carboxylate - methyl (4R)-6-tert-butyl-4-[(E)-2-(4-chlorophenyl)ethenyl]-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate - methyl (4R)-6-tert-butyl-4-[(E)-2-(4-fluorophenyl)ethenyl]-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate - methyl (4R)-6-tert-butyl-4-[(E)-2-(4-methoxyphenyl)ethenyl]-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate - methyl (4R)-6-tert-butyl-4-[(E)-2-(4-methylphenyl)ethenyl]-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate - methyl (4R)-6-tert-butyl-4-[(E)-2-(4-nitrophenyl)ethenyl]-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate - methyl (4R)-6-tert-butyl-4-[(E)-2-phenylethenyl]-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate - methyl 2,4-dihydroxy-6-methylbenzoate - isolated from a methanol extract of the Antarctic lichen Stereocaulon alpinum methyl 2-(3-(1-(4-fluorobenzyl)-6-nitro-4-oxo-1,4-dihydroquinoline-3-carboxamido)propoxy)-6-hydroxybenzoate - IC50 of 6.5 mg/ml methyl 2-(3-(1-benzyl-7-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxamido)propoxy)-6-hydroxybenzoate - IC50 of 9.4 mg/ml methyl 2-[4-[(4-[[ethoxy(oxo)acetyl][2-(methoxycarbonyl)phenyl]amino]-3-ethylphenylalanyl)amino]butoxy]-6-hydroxybenzoate - methyl 3,8-dimethoxy-11-oxo-1-pentanoyl-6-pentyl-11H-dibenzo[b,e][1,4]dioxepine-7-carboxylate - isolated from a methanol extract of the Antarctic lichen Stereocaulon alpinum methyl 3-formyl-2,4-dihydroxy-6-methylbenzoate - isolated from a methanol extract of the Antarctic lichen Stereocaulon alpinum methyl 4,4-dimethyl-3-oxochol-5-en-24-oate - - methyl 5-amino-6-(7-amino-6-methoxy-5,8-dioxo-5,8-dihydroquinolin-2-yl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methylpyridine-2-carboxylate - methyl 8-hydroxy-3-methoxy-11-oxo-1-pentanoyl-6-pentyl-11H-dibenzo[b,e][1,4]dioxepine-7-carboxylate - isolated from a methanol extract of the Antarctic lichen Stereocaulon alpinum methyl oleanolic acid amide - methyl oleanolic acid ester - methyl phenylcarbamate - methyl-5-((3-(benzylcarbamoyl)-6-iodo-4-oxoquinolin-1(4H)-yl)methyl)-2-methoxybenzoate - IC50 of more than 20 mg/ml Mg2+ - - Mn2+ - - mokko lactone - 93.1% PTP1B inhibitory activity with 0.00141 mg/ml molybdate mpV(pic) - potent and selective PTP inhibitor, inhibits SPH-1 in a dose-dependent manner MSI-1436 small molecule inhibitor MSI-1436 binds to the disordered C-terminal domain of PTP1B, C-terminal to the catalytic domain, MSI-1436 functions using an allosteric mechanism to direct the enzymatic activity of PTP1B N,1-dibenzyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxamide - 41.4% inhibition at 0.02 mg/ml N,1-dibenzyl-6-iodo-4-oxo-1,4-dihydroquinoline-3-carboxamide - 61.8% inhibition at 0.02 mg/ml N,N'-[benzene-1,4-diylbis(propane-2,2-diylbenzene-4,1-diyl)]bis(1,1,1-trifluoromethanesulfonamide) - - N-((4-((E)-2-nitroethenyl)phenyl)carbonyl)glycyl-L-alpha-glutamyl-L-glutamic acid - 50% inhibition at 0.0014 mM in absence of 2-mercaptoethanol, at 0.275 mM in presence of 1 mM 2-mercaptoethanol N-((4-(difluoro(phosphono)methyl)phenyl)acetyl)-L-a-aspartyl-4-(difluoro(phosphono)methyl)-L-phenylalaninamide - inhibition of enzyme increases caveolin-1 phosphorylation N-((4-(difluoro(phosphono)methyl)phenyl)acetyl)-L-alpha-aspartyl-4-(difluoro(phosphono)methyl)-L-phenylalaninamide - - N-(1,3-benzothiazol-2-yl)-2-chloroacetamide modeling of PTP1B bound to the compound N-(1,4-dioxo-1,4-dihydronaphthalen-2-yl)-N-(4-methylphenyl)acetamide - N-(3-chloro-4-fluorophenyl)-2-[(6,7-dimethoxy-4-oxo-3-phenyl-3,4-dihydro-2-quinazolinyl)sulfanyl]acetamide 80% inhibition at 0.2 mM N-(3-formylphenyl)-3-(((3-((3-formylphenyl)carbamoyl)phenyl)carbamoyl)amino)benzamide - suramin-derivative, 50% inhibition of PTP1B above 0.1 mM, reversible and competitive
IV Therapy: Immediate hydration and nutrient absorption often felt within an hour or two Benefits such as improved mental clarity, reduced fatigue, and brighter skin may develop over several hours to days Because IV therapy bypasses the digestive system, the nutrients go straight to work
Glutathione (GSH) is a short string of amino acids called a peptide
LncFASA promotes cancer ferroptosis via modulating PRDX1 phase separation
Bhandari, N
Exercise, estrogen, and ischemic cardioprotection by heat shock protein 70
